By
Latest Stories
Don’t miss our hot and upcoming stories
Gilead Expands AI-Driven Drug Discovery Capabilities Through Strategic Collaboration with Genesis Therapeutics
BURLINGAME, California – Sept 10, 2024 Gilead Sciences, Inc. (Nasdaq: GILD) and Genesis Therapeutics have…
Sanofi Taps Atomwise in $1B+ AI Drug Pact Covering Five High-Value Targets
Key Highlights San Francisco — Atomwise, a pioneer in artificial intelligence for small molecule drug…
How Stryker’s Acquisition of care.ai Strengthens Its Push Toward Smart, Connected Hospitals
Stryker to acquire care.ai to elevate virtual care workflows and expand its healthcare IT leadership…
AI-Powered Clinical Trials: How Unlearn AI, AbbVie, and Johnson & Johnson are Transforming Alzheimer’s Research
July 30, 2024 Artificial intelligence (AI) is revolutionizing clinical trials, offering greater efficiency and precision.…